Share
739 Posts.
lightbulb Created with Sketch. 73
clock Created with Sketch. 08/10/20
14:50
Share
Originally posted by jellyroll:
↑
Yes, feels like something is going on. Nearly all of my shares have been borrowed so there is a bit of a battle going on between the long and the short side. Personally I think at the forthcoming AGM, item 4, relating to the issue of options to the CEO is very interesting. The exercise price is $0.782 but the vesting criteria is either of i) US$ 7.5 million of EBIT in any one year (that is EBIT not EBITDA) that is @ A$10 million or ii) The completion of a commercial deal with a pharmaceutical company to utilize Cogstate's technology for the triaging of patients into the prescription of an Alzheimer's disease modifying drug, AND the approval of the drug in question by the FDA.
Expand
https://www.alzforum.org/news/research-news/fda-advisors-will-take-aducanumab-november-6 November 6th
(20min delay)